Study protocol for a prospective, non-controlled, multicentre clinical study to evaluate the diagnostic accuracy of a stepwise two-photon excited melanin fluorescence in pigmented lesions suspicious for melanoma (FLIMMA study)

BMJ Open. 2016 Dec 19;6(12):e012730. doi: 10.1136/bmjopen-2016-012730.

Abstract

Introduction: Non-invasive, nanosecond, stepwise two-photon laser excitation of skin tissue was shown to induce melanin fluorescence spectra that allow for the differentiation of melanocytic nevi from cutaneous melanoma.

Methods and analysis: This prospective, non-controlled, multicentre clinical study is performed to evaluate the diagnostic performance of the stepwise two-photon excited melanin fluorescence in the detection of cutaneous melanoma. The comparator will be the histopathological diagnosis. A total of 620 pigmented skin lesions suspicious for melanoma and intended for excision will be enrolled.

Ethics and dissemination: Ethics approval was provided by the local ethics committees of the medical faculties of the University of Tuebingen, Heidelberg and Berlin.

Study registration: The FLIMMA study NCT02425475.

Keywords: Diagnostic; Magnosco dermatofluoroscope; Melanin fluorescence; Melanoma; Two step photon excitation.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cutaneous Malignant Melanoma
  • Diagnosis, Differential
  • Germany
  • Humans
  • Melanoma / diagnosis*
  • Microscopy, Fluorescence, Multiphoton / methods*
  • Nevus, Pigmented / diagnosis*
  • Prospective Studies
  • Research Design
  • Skin / pathology
  • Skin Neoplasms / diagnosis*

Associated data

  • ClinicalTrials.gov/NCT02425475